Sendai virus infection induces apoptosis through activation of caspase-8 (FLICE) and caspase-3 (CPP32). 1999

M Bitzer, and F Prinz, and M Bauer, and M Spiegel, and W J Neubert, and M Gregor, and K Schulze-Osthoff, and U Lauer
Abteilung Innere Medizin I, Medizinische Universitätsklinik Tübingen, 72076 Tübingen, Germany. michael.bitzer@uni-tuebingen.de

Sendai virus (SV) infection and replication lead to a strong cytopathic effect with subsequent death of host cells. We now show that SV infection triggers an apoptotic program in target cells. Incubation of infected cells with the peptide inhibitor z-VAD-fmk abrogated SV-induced apoptosis, indicating that proteases of the caspase family were involved. Moreover, proteolytic activation of two distinct caspases, CPP32/caspase-3 and, as shown for the first time in virus-infected cells, FLICE/caspase-8, could be detected. So far, activation of FLICE/caspase-8 has been described in apoptosis triggered by death receptors, including CD95 and tumor necrosis factor (TNF)-R1. In contrast, we could show that SV-induced apoptosis did not require TNF or CD95 ligand. We further found that apoptosis of infected cells did not influence the maturation and budding of SV progeny. In conclusion, SV-induced cell injury is mediated by CD95- and TNF-R1-independent activation of caspases, leading to the death of host cells without impairment of the viral life cycle.

UI MeSH Term Description Entries
D011480 Protease Inhibitors Compounds which inhibit or antagonize biosynthesis or actions of proteases (ENDOPEPTIDASES). Antiprotease,Endopeptidase Inhibitor,Endopeptidase Inhibitors,Peptidase Inhibitor,Peptidase Inhibitors,Peptide Hydrolase Inhibitor,Peptide Hydrolase Inhibitors,Peptide Peptidohydrolase Inhibitor,Peptide Peptidohydrolase Inhibitors,Protease Antagonist,Protease Antagonists,Antiproteases,Protease Inhibitor,Antagonist, Protease,Antagonists, Protease,Hydrolase Inhibitor, Peptide,Hydrolase Inhibitors, Peptide,Inhibitor, Endopeptidase,Inhibitor, Peptidase,Inhibitor, Peptide Hydrolase,Inhibitor, Peptide Peptidohydrolase,Inhibitor, Protease,Inhibitors, Endopeptidase,Inhibitors, Peptidase,Inhibitors, Peptide Hydrolase,Inhibitors, Peptide Peptidohydrolase,Inhibitors, Protease,Peptidohydrolase Inhibitor, Peptide,Peptidohydrolase Inhibitors, Peptide
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002642 Chick Embryo The developmental entity of a fertilized chicken egg (ZYGOTE). The developmental process begins about 24 h before the egg is laid at the BLASTODISC, a small whitish spot on the surface of the EGG YOLK. After 21 days of incubation, the embryo is fully developed before hatching. Embryo, Chick,Chick Embryos,Embryos, Chick
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000882 Haplorhini A suborder of PRIMATES consisting of six families: CEBIDAE (some New World monkeys), ATELIDAE (some New World monkeys), CERCOPITHECIDAE (Old World monkeys), HYLOBATIDAE (gibbons and siamangs), CALLITRICHINAE (marmosets and tamarins), and HOMINIDAE (humans and great apes). Anthropoidea,Monkeys,Anthropoids,Monkey
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis
D053148 Caspase 3 A short pro-domain caspase that plays an effector role in APOPTOSIS. It is activated by INITIATOR CASPASES such as CASPASE 9. Isoforms of this protein exist due to multiple alternative splicing of its MESSENGER RNA. CASP3,Apopain,Caspase-3,Pro-Caspase-3,Procaspase-3,Pro Caspase 3,Procaspase 3

Related Publications

M Bitzer, and F Prinz, and M Bauer, and M Spiegel, and W J Neubert, and M Gregor, and K Schulze-Osthoff, and U Lauer
August 2006, Journal of veterinary medicine. B, Infectious diseases and veterinary public health,
M Bitzer, and F Prinz, and M Bauer, and M Spiegel, and W J Neubert, and M Gregor, and K Schulze-Osthoff, and U Lauer
November 1998, Proceedings of the National Academy of Sciences of the United States of America,
M Bitzer, and F Prinz, and M Bauer, and M Spiegel, and W J Neubert, and M Gregor, and K Schulze-Osthoff, and U Lauer
October 1996, FEBS letters,
M Bitzer, and F Prinz, and M Bauer, and M Spiegel, and W J Neubert, and M Gregor, and K Schulze-Osthoff, and U Lauer
October 2007, Virology,
M Bitzer, and F Prinz, and M Bauer, and M Spiegel, and W J Neubert, and M Gregor, and K Schulze-Osthoff, and U Lauer
August 2009, Blood,
M Bitzer, and F Prinz, and M Bauer, and M Spiegel, and W J Neubert, and M Gregor, and K Schulze-Osthoff, and U Lauer
April 2000, Journal of virology,
M Bitzer, and F Prinz, and M Bauer, and M Spiegel, and W J Neubert, and M Gregor, and K Schulze-Osthoff, and U Lauer
March 2010, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association,
M Bitzer, and F Prinz, and M Bauer, and M Spiegel, and W J Neubert, and M Gregor, and K Schulze-Osthoff, and U Lauer
May 2001, International journal of oncology,
M Bitzer, and F Prinz, and M Bauer, and M Spiegel, and W J Neubert, and M Gregor, and K Schulze-Osthoff, and U Lauer
November 2004, The Journal of general virology,
M Bitzer, and F Prinz, and M Bauer, and M Spiegel, and W J Neubert, and M Gregor, and K Schulze-Osthoff, and U Lauer
September 2010, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!